Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035685 | SCV000059336 | likely benign | not specified | 2010-12-28 | criteria provided, single submitter | clinical testing | This variant is not expected to have clinical significance because it does not a lter an amino acid residue and is not located near a splice junction. |
Labcorp Genetics |
RCV000469858 | SCV000558147 | likely benign | Hypertrophic cardiomyopathy | 2024-12-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001190897 | SCV001358532 | likely benign | Cardiomyopathy | 2018-12-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001689584 | SCV001909244 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002371822 | SCV002687394 | likely benign | Cardiovascular phenotype | 2022-02-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000469858 | SCV004834702 | likely benign | Hypertrophic cardiomyopathy | 2024-01-11 | criteria provided, single submitter | clinical testing |